The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Heinrikson, R. L., & Meredith, S. C. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90307-5 · Cited by 1,635
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Self-citation(1987) · Springer eBooks · doi:10.1007/978-3-642-45619-0 · Cited by 459
Carbohydrate Metabolism and Its Disorders.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-5-1032 · Cited by 412
Correlation between muscle glycogen synthase activity and in vivo insulin action in man
Bogardus, C., Lillioja, S., Stone, K., & Mott, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111304 · Cited by 335
Tschopp, F. A., Henke, H., Petermann, J. B., Tobler, P. H., Janzer, R., Hökfelt, T., Lundberg, J. M., Cuello, C., & Fischer, J. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.248 · Cited by 279
Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells
Mason, R. T., Peterfreund, R. A., Sawchenko, P. E., Corrigan, A. Z., Rivier, J. E., & Vale, W. W. (1984) · Nature · doi:10.1038/308653a0 · Cited by 250
Opie, E. L. (1901) · Journal of Experimental Medicine · doi:10.1084/jem.5.4.397 · Cited by 205
Cited by
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765
The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 660
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 583
VAN ROSSUM, D., HANISCH, U.-K., & QUIRION, R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00023-1 · Cited by 516
Maggi, C. A. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(94)e0017-b · Cited by 470
Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin
Mirzabekov, T. A., Lin, M.-C., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
Lukinius, A., Wilander, E., Westermark, G. T., Engstr�m, U., & Westermark, P. (1989) · Diabetologia · doi:10.1007/bf00285291 · Cited by 371
Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans
Butler, P. C., Chou, J., Carter, W. B., Wang, Y.-N., Bu, B.-H., Chang, D., Chang, J.-K., & Rizza, R. A. (1990) · Diabetes · doi:10.2337/diab.39.6.752 · Cited by 330
Polymorphic Fibrillar Assembly of Human Amylin
Goldsbury, C. S., Cooper, G. J. S., Goldie, K. N., Müller, S. A., Saafi, E. L., Gruijters, W. T. M., Misur, M. P., Engel, A., Aebi, U., & Kistler, J. (1997) · Journal of Structural Biology · doi:10.1006/jsbi.1997.3858 · Cited by 293
Self-citationS-Nitrosation of the Insulin Receptor, Insulin Receptor Substrate 1, and Protein Kinase B/Akt
Carvalho-Filho, M. A., Ueno, M., Hirabara, S. M., Seabra, A. B., Carvalheira, J. B. C., de Oliveira, M. G., Velloso, L. A., Curi, R., & Saad, M. J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.959 · Cited by 277
Increased Insulin Secretion and Glucose Tolerance in Mice Lacking Islet Amyloid Polypeptide (Amylin)
Gebre-Medhin, S., Mulder, H., Pekny, M., Westermark, G., Törnell, J., Westermark, P., Sundler, F., Ahrén, B., & Betsholtz, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9308 · Cited by 157
Enoki, S., Mitsukawa, T., Takemura, J., Nakazato, M., Aburaya, J., Toshimori, H., & Matsukara, S. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90074-2 · Cited by 118
Islet Amyloid Polypeptide Response to Glucose, Insulin, and Somatostatin Analogue Administration
Mitsukawa, T., Takemura, J., Asai, J., Nakazato, M., Kangawa, K., Matsuo, H., & Matsukura, S. (1990) · Diabetes · doi:10.2337/diab.39.5.639 · Cited by 122
In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit
Datta, H. K., Zaidi, M., Wimalawansa, S. J., Ghatei, M. A., Beacham, J. L., Bloom, S. R., & MacIntyre, I. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92391-7 · Cited by 114
Secretion of islet amyloid polypeptide in response to glucose
Kanatsuka, A., Makino, H., Ohsawa, H., Tokuyama, Y., Yamaguchi, T., Yoshida, S., & Adachi, M. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81527-3 · Cited by 107
Cornish, J., Callon, K. E., King, A. R., Cooper, G. J. S., & Reid, I. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e694 · Cited by 102
Self-citationThe regulation of total creatine content in a myoblast cell line
Odoom, J., Kemp, G., & Radda, G. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00225844 · Cited by 101
Wang, F., Hull, R. L., Vidal, J., Cnop, M., & Kahn, S. E. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2514 · Cited by 77
Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes
Bretherton-Watt, D., Ghatei, M. A., Bloom, S. R., Jamal, H., Ferrier, G. J. M., Girgis, S. I., & Legon, S. (1989) · Diabetologia · doi:10.1007/bf00297454 · Cited by 71
β‐cell mass in people with type 2 diabetes
Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69
AMYLINAMIDE, BONE CONSERVATION, AND PANCREATIC β CELLS
Macintyre, I. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91028-3 · Cited by 56
Amylin Stimulates Plasma Renin Concentration in Humans
Cooper, M. E., McNally, P. G., Phillips, P. A., & Johnston, C. I. (1995) · Hypertension · doi:10.1161/01.hyp.26.3.460 · Cited by 50
Towhidul Alam, A. S. M., Moonga, B. S., Bevis, P. J. R., Huang, C. L.-H., & Zaidi, M. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91345-d · Cited by 46
Effects of Amylin on Human Osteoblast-Like Cells
Villa, I., Rubinacci, A., Ravasi, F., Ferrara, A. F., & Guidobono, F. (1997) · Peptides · doi:10.1016/s0196-9781(97)00056-9 · Cited by 45
Mechanism of action of amylin in bone
Tamura, T., Miyaura, C., Owan, I., & Suda, T. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530103 · Cited by 42
Mulder, H., Ahrén, B., & Sundler, F. (1996) · Diabetologia · doi:10.1007/bf00418536 · Cited by 31
Metadata
- Authors
- Leighton, B., & Cooper, G. J. S.
- Venue
- Nature
- Published
- 1988-10
- Volume
- 335
- Issue
- 6191
- Pages
- 632-635
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2034109892
- Cited by
- 473
- References
- 23
- FWCI
- 53.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.